Cretney E - Search Results

1

Differential tumor surveillance by natural killer (NK) and NKT cells.

Smyth MJ, Thia KY, Street SE, Cretney E, Trapani JA, Taniguchi M, Kawano T, Pelikan SB, Crowe NY, Godfrey DI. Smyth MJ, et al. Among authors: cretney e. J Exp Med. 2000 Feb 21;191(4):661-8. doi: 10.1084/jem.191.4.661. J Exp Med. 2000. PMID: 10684858 Free PMC article.

2

Normal thymocyte negative selection in TRAIL-deficient mice.

Cretney E, Uldrich AP, Berzins SP, Strasser A, Godfrey DI, Smyth MJ. Cretney E, et al. J Exp Med. 2003 Aug 4;198(3):491-6. doi: 10.1084/jem.20030634. J Exp Med. 2003. PMID: 12900523 Free PMC article.

3

NKG2D function protects the host from tumor initiation.

Smyth MJ, Swann J, Cretney E, Zerafa N, Yokoyama WM, Hayakawa Y. Smyth MJ, et al. Among authors: cretney e. J Exp Med. 2005 Sep 5;202(5):583-8. doi: 10.1084/jem.20050994. Epub 2005 Aug 29. J Exp Med. 2005. PMID: 16129707 Free PMC article.

4

Perforin is a major contributor to NK cell control of tumor metastasis.

Smyth MJ, Thia KY, Cretney E, Kelly JM, Snook MB, Forbes CA, Scalzo AA. Smyth MJ, et al. Among authors: cretney e. J Immunol. 1999 Jun 1;162(11):6658-62. J Immunol. 1999. PMID: 10352283

5

m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection.

Cretney E, Degli-Esposti MA, Densley EH, Farrell HE, Davis-Poynter NJ, Smyth MJ. Cretney E, et al. J Exp Med. 1999 Aug 2;190(3):435-44. doi: 10.1084/jem.190.3.435. J Exp Med. 1999. PMID: 10430631 Free PMC article.

6

Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.

Street SE, Cretney E, Smyth MJ. Street SE, et al. Among authors: cretney e. Blood. 2001 Jan 1;97(1):192-7. doi: 10.1182/blood.v97.1.192. Blood. 2001. PMID: 11133760 Free article.

7

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.

Smyth MJ, Cretney E, Takeda K, Wiltrout RH, Sedger LM, Kayagaki N, Yagita H, Okumura K. Smyth MJ, et al. Among authors: cretney e. J Exp Med. 2001 Mar 19;193(6):661-70. doi: 10.1084/jem.193.6.661. J Exp Med. 2001. PMID: 11257133 Free PMC article.

8

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development.

Takeda K, Smyth MJ, Cretney E, Hayakawa Y, Kayagaki N, Yagita H, Okumura K. Takeda K, et al. Among authors: cretney e. J Exp Med. 2002 Jan 21;195(2):161-9. doi: 10.1084/jem.20011171. J Exp Med. 2002. PMID: 11805143 Free PMC article.

9

NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer.

Smyth MJ, Swann J, Kelly JM, Cretney E, Yokoyama WM, Diefenbach A, Sayers TJ, Hayakawa Y. Smyth MJ, et al. Among authors: cretney e. J Exp Med. 2004 Nov 15;200(10):1325-35. doi: 10.1084/jem.20041522. J Exp Med. 2004. PMID: 15545356 Free PMC article.

10

Activation of NK cell cytotoxicity.

Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y. Smyth MJ, et al. Among authors: cretney e. Mol Immunol. 2005 Feb;42(4):501-10. doi: 10.1016/j.molimm.2004.07.034. Mol Immunol. 2005. PMID: 15607806 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters